Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6013471 | Epilepsy & Behavior | 2013 | 8 Pages |
Abstract
CGP7930 decreased duration of ADs in 12-day-old but not in older rats. Motor phenomena (movements accompanying stimulation and clonic seizures) were not changed. CGP7930 only moderately affected sensorimotor performance, altered slightly spontaneous behavior in the open field, and did not influence behavior in the elevated plus maze in terms of an adaptive form of learning or anxiety-like behavior. Marked anticonvulsant action with subtle deficits in sensorimotor performance in 12-day-old rats suggests a possible use of CGP7930 as an age-specific anticonvulsant.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Pavel MareÅ¡, KateÅina Tichá, Anna Mikulecká,